74853-69-3 Usage
Uses
Used in Biochemistry Research:
AC-ARG-ARG-PRO-TYR-ILE-LEU-OH is used as a research tool for studying the interactions between peptides and other biomolecules, such as cell membranes or receptor sites. Its unique amino acid composition and sequence arrangement make it a valuable candidate for understanding peptide-biomacromolecule interactions.
Used in Drug Development:
In the pharmaceutical industry, AC-ARG-ARG-PRO-TYR-ILE-LEU-OH is used as a potential lead compound for the development of new drugs. Its bioactivity and ability to interact with cell membranes or receptor sites suggest that it may have therapeutic applications, particularly in the treatment of various diseases.
Used in Medicine:
AC-ARG-ARG-PRO-TYR-ILE-LEU-OH is used as a therapeutic agent in medicine, leveraging its potential interactions with cell membranes or receptor sites to modulate biological processes. Its specific amino acid composition and sequence arrangement may contribute to its efficacy in treating certain conditions or diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 74853-69-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,4,8,5 and 3 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 74853-69:
(7*7)+(6*4)+(5*8)+(4*5)+(3*3)+(2*6)+(1*9)=163
163 % 10 = 3
So 74853-69-3 is a valid CAS Registry Number.
InChI:InChI=1/C40H66N12O9/c1-6-23(4)32(36(58)50-30(38(60)61)20-22(2)3)51-34(56)29(21-25-13-15-26(54)16-14-25)49-35(57)31-12-9-19-52(31)37(59)28(11-8-18-46-40(43)44)48-33(55)27(47-24(5)53)10-7-17-45-39(41)42/h13-16,22-23,27-32,54H,6-12,17-21H2,1-5H3,(H,47,53)(H,48,55)(H,49,57)(H,50,58)(H,51,56)(H,60,61)(H4,41,42,45)(H4,43,44,46)/t23-,27-,28-,29-,30-,31-,32-/m0/s1
74853-69-3Relevant academic research and scientific papers
Corneal therapeutic agent
-
, (2008/06/13)
A corneal therapeutic agent comprises at least one of a hexapeptide and a pharmacologically acceptable salt thereof, represented by formula (I) shown below, and a pharmacologically acceptable carrier, where A is L- or D-arginine or lysine whose N-terminal amino group is deaminated, alkylated or acylated; B is L- or D-arginine, lysine or hystidine; Pro is L- or D-proline; C is L- or D-tyrosine, tryptophane, or phenylalanine; D is L- or D-valine, isoleucine, or leucine having an amino group whose hydrogen atom may be substituted with an alkyl group having 1 to 4 carbon atoms; E is L- or D-valine, isoleucine or leucine having a C-terminal carboxylic group which is unsubstituted or substituted with --COOR, --CH2 OR or --CONHR, where R represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms.
